Table 3.

Cox regression analyses

	145 patients		157 patients
	PFS		OS
	HR (95% CI)	P value	HR (95% CI)	P value
Age at first ASCT	1.1 (0.93 to 1.31)	0.24	1.21 (1.02 to 1.43)	0.029
Histology
Leiomyosarcoma (reference)
Liposarcoma	0.86 (0.43 to 1.72)	0.67	0.75 (0.37 to 1.55)	0.44
Synovial sarcoma	1.2 (0.63 to 2.26)	0.58	1.4 (0.72 to 2.72)	0.32
Angiosarcoma	1.24 (0.66 to 2.32)	0.50	1.25 (0.64 to 2.47)	0.51
Other sarcoma	1.24 (0.76 to 2.01)	0.40	1.11 (0.65 to 1.89)	0.70
Remission status prior ASCT
CR/NED (reference)
PR+SD	1.49 (0.92 to 2.41)	0.10	1.48 (0.87 to 2.53)	0.15
PD	2.78 (1.62 to 4.77)	0.0002	3 (1.69 to 5.32)	0.0002
Preparative regimen
Platinum based (reference)
Melphalan based	0.61 (0.38 to 0.97)	0.036	0.85 (0.52 to 1.4)	0.53
Other	0.7 (0.41 to 1.22)	0.21	1.2 (0.68 to 2.13)	0.52

Bold numbers denote statistical significance (p < 0.05).

ASCT, autologous stem cell transplantation; CR, complete remission; NED, no evidence of disease; OS, overall survival; PD, progressive disease; PFS, progression-free survival; PR, partial remission; SD, stable disease.